Synapse Peptides
GLP2-T
View COA (PDF)
Lot SPTIRZ001 · 99.72% purity · Tested 2026-07-07
Overview
Synthetic dual GIP/GLP-1 receptor agonist peptide. Reference compound for studies of incretin signalling and metabolic regulation.
Compound data
- Lot
- SPTIRZ001
- Purity
- 99.72%
- Assay method
- HPLC-MS
- Test date
- 2026-07-07
- Molecular weight
- 4813.5 g/mol
- Manufacture
- EU GMP
- Sequence
Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{C20 diacid-gamma-Glu-(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
Description
Synthetic Reference Compound For Laboratory Research And Analytical Applications, Supporting Experimental And Investigative Studies In Controlled Research Environments. Strictly Intended For Laboratory Use Only. Not For Human Or Animal Use, Consumption, Or Therapeutic Use.
Research use
All products are supplied for laboratory and research use only and are not for human consumption, diagnostic, or therapeutic use.
Related products
-
LOT SPRETA001
Select options This product has multiple variants. The options may be chosen on the product page
-
LOT SPCAGR001
Select options This product has multiple variants. The options may be chosen on the product page
-
LOT SPSEM001
Select options This product has multiple variants. The options may be chosen on the product page
-
LOT SP5AMQ001
Select options This product has multiple variants. The options may be chosen on the product page
